Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blinatumomab”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Early research (Phase 1)Study completedNCT02568553
What this trial is testing

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Burkitt LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+23 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Not Yet RecruitingNCT07283640
What this trial is testing

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

Who this might be right for
BlinatumomabRevumenibLymphoblastic Leukemia+1 more
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT02000427
What this trial is testing

Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed/Refractory Philadelphia Positive B-precursor ALL
Amgen 45
Early research (Phase 1)Study completedNCT02961881
What this trial is testing

A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen 35
Early research (Phase 1)Study completedNCT03751709
What this trial is testing

Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL

Who this might be right for
B-Cell Acute Lymphoblastic LeukaemiaALL, AdultB-ALL
Cedars-Sinai Medical Center 22
Not applicableUnknownNCT04723342
What this trial is testing

Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot

Who this might be right for
Childhood Acute Lymphoblastic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 180
Testing effectiveness (Phase 2)Study completedNCT01471782
What this trial is testing

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen Research (Munich) GmbH 93
Not applicableUnknownNCT05837689
What this trial is testing

Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
Xiaojun Xu 20
Early research (Phase 1)WithdrawnNCT03605589
What this trial is testing

Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma

Who this might be right for
Leukemia, B-cellLymphoma, B-Cell
Children's Hospital Medical Center, Cincinnati
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06438796
What this trial is testing

Blinatumomab Maintenance After Allo-HSCT

Who this might be right for
High Risk Acute Lymphoblastic Leukemia
Ruijin Hospital 59
Testing effectiveness (Phase 2)Ended earlyNCT04044560
What this trial is testing

Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaStem Cell LeukemiaMinimal Residual Disease
University of British Columbia 8
Testing effectiveness (Phase 2)Ended earlyNCT03523429
What this trial is testing

PETHEMA-BLIN-01/PET069014 (BLIN-01)

Who this might be right for
Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
PETHEMA Foundation 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06930105
What this trial is testing

Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL

Who this might be right for
Acute Lymphoid Leukemia (ALL)
Xianmin Song, MD 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03114865
What this trial is testing

Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Who this might be right for
Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaPre B-Cell Acute Lymphoblastic Leukaemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Testing effectiveness (Phase 2)Study completedNCT02412306
What this trial is testing

Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia
Amgen 66
Early research (Phase 1)Looking for participantsNCT03595917
What this trial is testing

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaChronic Myeloid Leukemia (CML) in Lymphoid Blast CrisisPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL
Marlise Luskin, MD 40
Not applicableNo Longer AvailableNCT02187354
What this trial is testing

Expanded Access Protocol - Blinatumomab in Pediatric & Adolescent Subjects With Relapsed/Refractory B-precursor ALL

Who this might be right for
Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Amgen
Large-scale testing (Phase 3)Not Yet RecruitingNCT06836973
What this trial is testing

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Da, Yuwei, M.D. 2
Not applicableStudy completedNCT03751072
What this trial is testing

Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed Remission
Group for Research in Adult Acute Lymphoblastic Leukemia 92
Testing effectiveness (Phase 2)Looking for participantsNCT06124157
What this trial is testing

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 222
Next Page